Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Casdin Eli
Relationship:   Director
City:   Madison
State:   WI
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   18,894,431    

Indirect Shares

  147,334,950      
Direct Value   $204,486,367    

Indirect Value

  $2,242,116,487      
Total Shares   166,229,381      
Total Value   $2,446,602,855      


Exact Sciences Corp
 $524,614 Biolife Solutions Inc
 $156,206,540 GeneDx Holdings Corp
 $1,123,248 Maxcyte, Inc.
 $46,400,000 Fluidigm Corp
 $231,965 2seventy Bio, Inc.
 $0 Exact Sciences Corp
 $524,614 Biolife Solutions Inc
 $156,206,540 GeneDx Holdings Corp
 $1,123,248 Maxcyte, Inc.
 $46,400,000 Fluidigm Corp
 $231,965 2seventy Bio, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    20   
    2    

     Stock price went up :

    10   
    0    
     Stock price went down :
    10   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
   23.8%
 -48.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Exact Sciences Corp EXAS Director 2020-07-23 8,820 2020-07-23 450    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 2019-07-22 0 2019-07-22 604,285    Premium*  
            Biolife Solutions Inc BLFS 10% Owner 2024-04-30 8,707,165 2024-04-30 0    Premium*  
            Generation Bio Co. GBIO 10% Owner 2020-06-16 0 2020-06-16 1,611,215    Premium*  
            Century Therapeutics, Inc. IPSC Director 2021-06-22 0 2021-06-22 3,206,380    Premium*  
            GeneDx Holdings Corp WGS Director 2023-05-02 58,290 2023-05-02 113,145,535    Premium*  
            Absci Corp ABSI Director 2021-07-26 0 2021-07-26 973,260    Premium*  
            Maxcyte, Inc. MXCT 10% Owner 2022-10-03 10,000,000 2021-07-30 0    Premium*  
            Tenaya Therapeutics, Inc. TNYA Director, 10% Owner 2021-08-03 0 2021-08-03 361,969    Premium*  
            Cm Life Sciences Ii Inc. SLGC Director, 10% Owner 2024-01-05 0 2024-01-05 0    Premium*  
            EQRx, Inc. EQRX 10% Owner 2021-12-17 0 2023-11-09 0    Premium*  
            Fluidigm Corp FLDM Director, 10% Owner 2024-03-18 103,556 2024-03-18 25,431,856    Premium*  
            2seventy Bio, Inc. TSVT Director 2024-03-26 16,600 2024-03-26 2,000,000    Premium*  
* Premium Members only  

Records found :    68         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TSVT 2seventy Bio, Inc. Director   –       •      –    2024-03-20 3 IO $0.00 $0 D/D 0 16,600 -
TSVT 2seventy Bio, Inc. Director   –       •      –    2024-03-20 3 IO $0.00 $0 I/I 0 1,182,623 -
TSVT 2seventy Bio, Inc. Director   –       •      –    2024-03-26 4 B $5.10 $203,992 I/I 40,000 2,000,000 2.1 -
ABSI Absci Corp Director   –       •      –    2021-07-26 4 A $0.00 $0 I/I 6,156,093 973,260 0 -
ABSI Absci Corp Director   –       •      –    2021-07-26 4 B $16.00 $25,000,000 I/I 1,562,500 6,745,333 2.1 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2019-11-19 4 B $15.15 $302,918 D/D 20,000 2,448,571 2.45 -
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2019-11-20 4 B $15.68 $313,618 D/D 20,000 2,468,571 2.45 -
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2020-05-14 4 B $10.50 $20,000,001 D/D 1,904,762 4,373,333 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2020-05-22 4 B $10.50 $5,000,006 D/D 476,191 4,849,524 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2020-07-01 4 B $14.50 $9,932,500 D/D 685,000 5,534,524 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2020-07-02 4 B $14.50 $4,430,954 D/D 305,583 5,840,107 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2020-11-24 4 B $22.50 $36,000,000 D/D 1,600,000 7,440,107 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2021-09-01 4/A A $0.00 $0 D/D 131,428 7,571,535 0 -
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2021-09-01 4 A $0.00 $0 D/D 126,185 7,566,292 0 -
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-05-16 4 B $20.19 $302,835 I/I 15,000 15,000 1.5 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-05-17 4 B $21.30 $639,446 I/I 30,027 45,027 1.5 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-05-18 4 B $21.76 $652,692 I/I 30,000 75,027 1.5 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-05-19 4 B $22.55 $1,127,430 I/I 50,000 125,027 1.5 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-05-22 4 B $21.86 $545,790 I/I 24,973 150,000 1.5 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-08-09 4 B $13.20 $771,744 D/D 58,465 7,630,000 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2023-10-19 4 B $11.19 $10,374,976 D/D 927,165 8,557,165 2.45 %
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2024-04-30 4 D $17.54 $2,631,000 I/I (150,000) 0 0 -
BLFS Biolife Solutions Inc 10% Owner   –       –       •   2024-04-30 4 A $17.54 $2,631,000 D/D 150,000 8,707,165 0 -
IPSC Century Therapeutics, Inc... Director   –       •      –    2021-06-22 4 B $20.00 $15,000,000 I/I 750,000 3,206,380 2.1 -
IPSC Century Therapeutics, Inc... Director   –       •      –    2021-06-22 4 A $0.00 $0 I/I 2,456,380 2,456,380 0 -

  68  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed